Skip to content
  • KOSPI 2649.78 -21.79 -0.82%
  • KOSDAQ 774.49 -4.69 -0.60%
  • KOSPI200 353.93 -2.51 -0.70%
  • USD/KRW 1329 -1.00 0.08%
View Market Snapshot

Deals

Mergers & Acquisitions

Celltrion eyes Baxter's arm as it gears up for M&As

Celltrion Inc., South Korea’s largest biosimilar maker, said on Tuesday it has studied a possible acquisition of the biopharma solutions unit of the US-based Baxter International Inc., a deal estimated at $4 billion.Celltrion is understood to

Mar 21, 2023 (Gmt+09:00)

2 Min read